{"id":"https://openalex.org/W2138449457","doi":"https://doi.org/10.1016/j.molonc.2007.01.003","title":"Cancer therapeutic antibodies come of age: Targeting minimal residual disease","display_name":"Cancer therapeutic antibodies come of age: Targeting minimal residual disease","alternate_titles":[],"publication_year":2007,"publication_date":"2007-03-14","ids":{"openalex":"https://openalex.org/W2138449457","doi":"https://doi.org/10.1016/j.molonc.2007.01.003","mag":"2138449457","pmid":"https://pubmed.ncbi.nlm.nih.gov/19383286","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5543854"},"language":"en","primary_location":{"id":"doi:10.1016/j.molonc.2007.01.003","doi":"https://doi.org/10.1016/j.molonc.2007.01.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molonc.2007.01.003","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2007.01.003","source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2138449457"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2007.01.003","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063719825","display_name":"Tsipi Ben-Kasus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tsipi Ben-Kasus","raw_affiliation_strings":["Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109325286","display_name":"Bilha Schechter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bilha Schechter","raw_affiliation_strings":["Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111494072","display_name":"Michael Sela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Sela","raw_affiliation_strings":["Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038055187","display_name":"Yosef Yarden","orcid":"https://orcid.org/0000-0003-4168-7884","observed_orcids":["https://orcid.org/0000-0003-4168-7884"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yosef Yarden","raw_affiliation_strings":["Department of Biological Regulation, The Feinberg Graduate School, The Weizmann Institute of Science, Room 302, Rehovot 76100, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, The Feinberg Graduate School, The Weizmann Institute of Science, Room 302, Rehovot 76100, Israel","institution_ids":["https://openalex.org/I53964585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5038055187"],"corresponding_institution_ids":["https://openalex.org/I53964585"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":0.3798,"has_fulltext":true,"cited_by_count":67,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.33042394,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"1","issue":"1","first_page":"42","last_page":"54"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.800000011920929},{"id":"https://openalex.org/keywords/antibody-based-therapy","display_name":"antibody-based therapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9049999713897705},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.843999981880188},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9629999995231628},{"id":"https://openalex.org/keywords/anti-cd20","display_name":"anti-CD20","score":0.8059999942779541},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.7990000247955322},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5910000205039978},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.6784648895263672},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5853955745697021},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5631682276725769},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5532179474830627},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5482920408248901},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42759186029434204},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35769397020339966},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3238176703453064},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26376697421073914},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.0903831422328949}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.molonc.2007.01.003","doi":"https://doi.org/10.1016/j.molonc.2007.01.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molonc.2007.01.003","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2007.01.003","source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5543854","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5543854/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Oncol","raw_type":"Text"},{"id":"pmid:19383286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19383286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.molonc.2007.01.003","doi":"https://doi.org/10.1016/j.molonc.2007.01.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molonc.2007.01.003","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2007.01.003","source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306163","display_name":"Prostate Cancer Foundation","ror":"https://ror.org/01npwtv09"},{"id":"https://openalex.org/F4320306740","display_name":"Israel Cancer Research Fund","ror":"https://ror.org/02h43gk75"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2138449457.pdf","grobid_xml":"https://content.openalex.org/works/W2138449457.grobid-xml"},"referenced_works_count":104,"referenced_works":["https://openalex.org/W35533511","https://openalex.org/W1490624051","https://openalex.org/W1490790087","https://openalex.org/W1509374036","https://openalex.org/W1531785323","https://openalex.org/W1546210634","https://openalex.org/W1549258100","https://openalex.org/W1570686199","https://openalex.org/W1613075622","https://openalex.org/W1645126533","https://openalex.org/W1665419471","https://openalex.org/W1665592746","https://openalex.org/W1804903119","https://openalex.org/W1854005499","https://openalex.org/W1890809256","https://openalex.org/W1915689252","https://openalex.org/W1964989552","https://openalex.org/W1965962344","https://openalex.org/W1966626410","https://openalex.org/W1966930760","https://openalex.org/W1967841898","https://openalex.org/W1968961303","https://openalex.org/W1983494459","https://openalex.org/W1985009080","https://openalex.org/W1989053318","https://openalex.org/W1994097025","https://openalex.org/W1995242599","https://openalex.org/W1997620264","https://openalex.org/W1999966784","https://openalex.org/W2010244981","https://openalex.org/W2014099862","https://openalex.org/W2014390504","https://openalex.org/W2016010426","https://openalex.org/W2016708646","https://openalex.org/W2024651005","https://openalex.org/W2026010658","https://openalex.org/W2026055716","https://openalex.org/W2028972436","https://openalex.org/W2030522563","https://openalex.org/W2031476786","https://openalex.org/W2031947830","https://openalex.org/W2033485934","https://openalex.org/W2034690275","https://openalex.org/W2034801324","https://openalex.org/W2036369606","https://openalex.org/W2043507805","https://openalex.org/W2044360617","https://openalex.org/W2046180857","https://openalex.org/W2050243165","https://openalex.org/W2051636537","https://openalex.org/W2054409932","https://openalex.org/W2057458801","https://openalex.org/W2057796652","https://openalex.org/W2059411043","https://openalex.org/W2064125258","https://openalex.org/W2065900855","https://openalex.org/W2067494581","https://openalex.org/W2068858577","https://openalex.org/W2069524809","https://openalex.org/W2072140252","https://openalex.org/W2074271171","https://openalex.org/W2077291494","https://openalex.org/W2079977894","https://openalex.org/W2084146339","https://openalex.org/W2092897704","https://openalex.org/W2092947970","https://openalex.org/W2094241271","https://openalex.org/W2094627540","https://openalex.org/W2095156669","https://openalex.org/W2096055205","https://openalex.org/W2098972292","https://openalex.org/W2100117577","https://openalex.org/W2100181294","https://openalex.org/W2107202569","https://openalex.org/W2107427447","https://openalex.org/W2108093856","https://openalex.org/W2112979829","https://openalex.org/W2116323570","https://openalex.org/W2117115931","https://openalex.org/W2118125481","https://openalex.org/W2123299533","https://openalex.org/W2128402413","https://openalex.org/W2138916760","https://openalex.org/W2141346487","https://openalex.org/W2144124503","https://openalex.org/W2145257123","https://openalex.org/W2146384083","https://openalex.org/W2149908785","https://openalex.org/W2154027407","https://openalex.org/W2154200023","https://openalex.org/W2155384808","https://openalex.org/W2159459001","https://openalex.org/W2160068811","https://openalex.org/W2160575379","https://openalex.org/W2162260323","https://openalex.org/W2163332468","https://openalex.org/W2168057516","https://openalex.org/W2168106779","https://openalex.org/W2168648203","https://openalex.org/W2169434055","https://openalex.org/W2171584014","https://openalex.org/W2222638000","https://openalex.org/W2318605753","https://openalex.org/W2408994916"],"related_works":["https://openalex.org/W1972201132","https://openalex.org/W2021147401","https://openalex.org/W2003594405","https://openalex.org/W2623347536","https://openalex.org/W2324449216","https://openalex.org/W2041818132","https://openalex.org/W4316019272","https://openalex.org/W2171255356","https://openalex.org/W2077657913","https://openalex.org/W115345674"],"abstract_inverted_index":{"Ten":[0],"years":[1],"after":[2],"the":[3,24,28,32,38,66,83,91],"first":[4],"clinical":[5],"application":[6,50],"of":[7,27,35,41,51,68,80,94],"Rituximab,":[8],"an":[9,53],"anti-CD20":[10],"recombinant":[11],"monoclonal":[12],"antibody,":[13],"immunotherapy":[14],"has":[15],"become":[16],"common":[17],"practice":[18],"in":[19,60,72],"oncology":[20],"wards.":[21],"Thanks":[22],"to":[23,55,86],"great":[25],"diversity":[26],"immune":[29],"system":[30],"and":[31,90],"powerful":[33],"methodology":[34],"genetic":[36],"engineering,":[37],"pharmacologic":[39],"potential":[40,93],"antibody-based":[42,81],"therapy":[43,64],"is":[44],"far":[45],"from":[46],"exhaustion.":[47],"The":[48],"recent":[49],"Trastuzumab,":[52],"antibody":[54],"a":[56,69],"receptor":[57],"tyrosine":[58],"kinase,":[59],"adjuvant":[61],"breast":[62],"cancer":[63,73],"marks":[65],"beginning":[67],"new":[70],"phase":[71],"treatment.":[74],"Here":[75],"we":[76],"discuss":[77],"molecular":[78],"mechanisms":[79],"therapy,":[82],"emerging":[84],"ability":[85],"target":[87],"minimal":[88],"disease":[89],"therapeutic":[92],"combining":[95],"antibodies":[96],"with":[97],"other":[98],"modalities.":[99]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2138449457","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
